EcoDrugPlus

Ensembl ID : ENSPSNG00000001636
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSPSNG00000008502
Gene Symbol: -
Cross references: -
103 Possible Orthologues:

Ensembl ID : ENSPSNG00000001489
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSPSNG00000006599
Gene Symbol: -
Cross references: -
340 Possible Orthologues:

Ensembl ID : ENSPSNG00000006503
Gene Symbol: -
Cross references: -
564 Possible Orthologues:

Ensembl ID : ENSPSNG00000006071
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSPSNG00000005960
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSPSNG00000016284
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSPSNG00000005737
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSPSNG00000005659
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSPSNG00000015482
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSPSNG00000003851
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).